Higher-Risk MDS and CMML: Azacitidine w/ Lenalidomide or With Vorinostat vs. Azacitidine Monotherapy
Study SWOG S1117 (Abstract LBA-5).
At ASH 2014, Dr. Mikkael Sekeres discussed his abstract titled A Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitid...
Author: feeds
Added: 04/15/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts